Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients

NCT06066008 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Retinoschisis

Interventions

DRUG: ZM-01-L
DRUG: ZM-01-H

Sponsor

Zhongmou Therapeutics